Figure 2. Abolishment of early phase clinical symptoms in mast cell-deficient mice. The clinical scores were also significantly lower in the sensitized mast cell-deficient mice than in sensitized wild type mice following multiple allergen exposures. An asterisk indicates that p<0.005. Fel d 1: sensitized with Fel d 1; PBS: mock-sensitized; n=10 mice/group.